Rituximab in recurrent idiopathic giant cell myocarditis after heart transplantation: a potential therapeutic approach

Diagnosis, Treatment, and Outcome of Giant-Cell Myocarditis in the Era of Combined Immunosuppression

(2012) Riina Kandolin et al.   Circulation-Heart Failure

Biologic agents in the treatment of granulomatosis with polyangiitis

(2012) U. SPECKS   CLEVELAND CLINIC JOURNAL OF MEDICINE

Idiopathic giant cell myocarditis and cardiac sarcoidosis

(2012) Lori A. Blauwet et al.   HEART FAILURE REVIEWS

Giant cell myocarditis

(2012) L.T. Cooper et al.   HERZ

LONG TERM RISK OF DEATH, TRANSPLANTATION AND DISEASE RECURRENCE IN GIANT CELL MYOCARDITIS

(2012) Leslie T. Cooper et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Advances in Therapy for ANCA-Associated Vasculitis

(2012) Duvuru Geetha et al.   Current Rheumatology Reports

B-cell depleting agents for ANCA vasculitides: A new therapeutic approach

(2011) José A. Gómez-Puerta et al.   AUTOIMMUNITY REVIEWS

Rituximab Maintenance Therapy for Granulomatosis with Polyangiitis and Microscopic Polyangiitis

(2011) C. ROUBAUD-BAUDRON et al.   JOURNAL OF RHEUMATOLOGY

Rituximab in childhood lupus myocarditis

(2011) Pooja Aggarwal et al.   RHEUMATOLOGY INTERNATIONAL

Usefulness of Immunosuppression for Giant Cell Myocarditis

(2008) Leslie T. Cooper et al.   AMERICAN JOURNAL OF CARDIOLOGY

Rituximab as a treatment alternative in sarcoidosis

(2008) Ahlam Belkhou et al.   JOINT BONE SPINE

Rituximab reversed cardiac involvement of Wegener's granulomatosis: magnetic resonance imaging assessment

(2008) Benoit Brihaye et al.   PRESSE MEDICALE